Not reported
Active07617346Private limited companyLondon
OXFORD GENETICS LTD
Significant control: Avant UK Buyer Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Oxford Genetics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Oxford Genetics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
OXFORD GENETICS LTD is an active private limited company (company number 07617346) incorporated on 28 April 2011, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest full accounts cover the period ending 31 December 2024 and cash of £1.13m, with 57 employees on average. Turnover was £2.58m and profit for the year −£6.10m.
There are 603 companies in research and experimental development on biotechnology in London with filed accounts; the median reports net assets of £440 and is 6 years old.
02
Ownership and control
- Avant Uk Buyer Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mercia Fund Management Limited
- has significant influence or control
- Mercia (General Partner) Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 28 April 201115 yrs ago
- Next accounts due
- 30 September 202624 days overdue
- Confirmation statement due
- 12 May 2027in 200 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£1.13m
−51%vs Dec 2023£2.58m
−72%vs Dec 202357
−45%vs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | — | £1.13m | — | — | £2.58m | −£6.10m | 57 |
| 31 December 2023 | — | £2.30m | — | — | £9.13m | −£3.60m | 103 |
| 1 January 2023 | — | — | — | — | — | — | — |
Net margin-236.8%Profit for the year ÷ turnover
Cash per employee£20kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Cash at bank of £50,000 or moreCash £1,134,542
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 28 April 2011
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 200 days
- Next accounts due24 days overdue
- Accounts period end
- Accounts period end
- Accounts period end
- Incorporated
08
Similar companies in London
- SYNTHESIS MED CHEM (UK) LIMITEDLondon · inc. May 2011
- COLBE R&D LIMITEDLondon · inc. May 2011
- ABIMMUNO LIMITEDLondon · inc. May 2011
- NANOGENICS LIMITEDLondon · inc. May 2011
- APTERNA LIMITEDLondon · inc. Mar 2011
- SYNTHACE LIMITEDLondon · inc. May 2011
All companies incorporated on 28 April 2011 · in Apr 2011.
09
Reminders for OXFORD GENETICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.